Peptone manufacturer Biotecnica (San Jacinto Amilpas, Mexico) is debuting a new line of low endotoxin peptones that do not need ultrafiltration.
The company created the EndoLow-branded peptones for use in the production of a variety of drugs, including vaccines and diagnostic products.
Offering high levels of nitrogen, vitamins and carbohydrates, peptones have ideal properties for cell cultures.
The Swiss botanist Carl Nägeli described peptones in 1880, which can be created by partially hydrolyzing proteins with acids, bases or proteolytic enzymes.
The EndoLow peptone line offers high levels of amino acids, polypeptides and carbohydrates while offering minimal endotoxin levels.
The line is available in three types, based on casein, bovine tissue and soy, respectively.
Biotecnica uses a Limulus amebocyte lysate (LAL) test to determine endotoxin labels in every EndoLow peptone lot. The company states that levels are below 200 EU/gr.
Filed Under: Drug Discovery and Development